Eugene Kennedy
Director Técnico/Científico/I+D en CARISMA THERAPEUTICS, INC. .
Fortuna: - $ al 31/05/2024
Cargos activos de Eugene Kennedy
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 02/05/2024 | - |
Historial de carrera de Eugene Kennedy
Antiguos cargos conocidos de Eugene Kennedy.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GALERA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/09/2022 | 01/09/2023 |
| LUMOS PHARMA, INC. | Director Técnico/Científico/I+D | 01/01/2014 | 06/03/2021 |
| Thomas Jefferson University | Corporate Officer/Principal | 01/01/2006 | 01/12/2013 |
| Innovative Cellular Therapeutics, Inc. | Director Técnico/Científico/I+D | - | - |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Director/Miembro de la Junta | - | - |
| LUMOS PHARMA, INC. | Director Técnico/Científico/I+D | 14/11/2017 | - |
Formación de Eugene Kennedy.
| University of Virginia | Undergraduate Degree |
| Medical College of Virginia | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 10 |
Operativa
| Chief Tech/Sci/R&D Officer | 5 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| GALERA THERAPEUTICS, INC. | Health Technology |
| LUMOS PHARMA, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
The Hope Funds for Cancer Research
The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Commercial Services |
| Innovative Cellular Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Eugene Kennedy
- Experiencia
